2023-09-11 07:24:59 ET
More on Immatics, Moderna, etc.
- Pfizer, Moderna And COVID Vaccine Patents: Implications Of Legal Cases
- Moderna: Buy Before The Fall Covid-19 Wave
- Moderna Falling As Vaccine Hesitancy Rises
- Moderna, Inc. ( MRNA ) Q2 2023 Earnings Call Transcript
- Moderna, Inc. 2023 Q2 - Results - Earnings Call Presentation
- BioNTech And Moderna: Fallen Angels Of The COVID Era Are Buys Ahead Of Earnings
- Immatics: Additional Gains Possible Q4 Of 2023 With Data Update Of IMA203
- Immatics Is Increasingly Becoming Interesting
- Moderna urges shareholders to reject "undervalued" mini-tender offer
- Moderna says COVID shot strongly responded to Pirola variant
- Alnylam appealing patent ruling in case against Moderna
For further details see:
Moderna in pact with Immatics for cancer therapeutics